Insider Buying: Starpharma Holdings Limited (ASX:SPL) Insider Purchases 200,000 Shares of Stock

Starpharma Holdings Limited (ASX:SPL) insider Robert Thomas bought 200,000 shares of the stock in a transaction that occurred on Wednesday, October 23rd. The shares were purchased at an average price of A$0.09 ($0.06) per share, with a total value of A$18,600.00 ($12,236.84).

Starpharma Stock Performance

The company has a debt-to-equity ratio of 12.55, a quick ratio of 5.65 and a current ratio of 4.94.

About Starpharma

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.